Apotex Health Corp. APTX.TO

APTX.TO Company Overview

Apotex Health Corp. (AOTXF) is associated with the broader Apotex pharmaceutical group, a Canadian-based manufacturer of generic and specialty pharmaceuticals. The company operates primarily in the global healthcare and pharmaceutical industries, with a focus on developing, manufacturing, and distributing generic medicines, over-the-counter products, and selected specialty therapies. Its core revenue drivers have historically been prescription generic drugs sold through retail pharmacies, hospitals, wholesalers, and institutional healthcare systems.

The company’s business model is centered on cost-competitive pharmaceutical manufacturing, regulatory approvals across multiple jurisdictions, and broad product distribution capabilities. Apotex has historically maintained a strong position in Canada’s generic drug market while also expanding into the United States and international markets. The company was founded in 1974 by Dr. Barry Sherman, and over time evolved from a domestic generic drug producer into an internationally active pharmaceutical organization with vertically integrated manufacturing and research capabilities.